Annual Total Long Term Liabilities
$7.05 M
+$6.28 M+811.77%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual total long term liabilities is $7.05 million, with the most recent change of +$6.28 million (+811.77%) on December 1, 2023.
- During the last 3 years, CATX annual total long term liabilities has risen by +$5.84 million (+482.96%).
- CATX annual total long term liabilities is now at all-time high.
Performance
CATX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$34.54 M
+$227.00 K+0.66%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly total long term liabilities is $34.54 million, with the most recent change of +$227.00 thousand (+0.66%) on September 1, 2024.
- Over the past year, CATX quarterly long term liabilities has increased by +$30.91 million (+850.70%).
- CATX quarterly long term liabilities is now at all-time high.
Performance
CATX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CATX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +811.8% | +850.7% |
| 3 y3 years | +483.0% | +1325.5% |
| 5 y5 years | +1034.9% | +1325.5% |
CATX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +811.8% | at high | +4036.4% |
| 5 y | 5-year | at high | +1034.9% | at high | +4036.4% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Perspective Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.54 M(+0.7%) |
| Jun 2024 | - | $34.31 M(+1.2%) |
| Mar 2024 | - | $33.89 M(+380.9%) |
| Dec 2023 | $7.05 M(+811.8%) | $7.05 M(+94.0%) |
| Sep 2023 | - | $3.63 M(+25.1%) |
| Jun 2023 | - | $2.90 M(+19.8%) |
| Mar 2023 | - | $2.42 M(+190.2%) |
| Dec 2022 | $773.00 K(-13.7%) | - |
| Sep 2022 | - | $835.00 K(-6.8%) |
| Jun 2022 | - | $896.00 K(-6.3%) |
| Jun 2022 | $896.00 K(-25.9%) | - |
| Mar 2022 | - | $956.00 K(-5.9%) |
| Dec 2021 | - | $1.02 M(-11.8%) |
| Sep 2021 | - | $1.15 M(-4.7%) |
| Jun 2021 | $1.21 M(-13.7%) | - |
| Jun 2021 | - | $1.21 M(-4.5%) |
| Mar 2021 | - | $1.27 M(-9.9%) |
| Dec 2020 | - | $1.41 M(-0.2%) |
| Sep 2020 | - | $1.41 M(+0.5%) |
| Jun 2020 | $1.40 M(+125.6%) | $1.40 M(+0.1%) |
| Mar 2020 | - | $1.40 M(-3.6%) |
| Dec 2019 | - | $1.45 M(-3.4%) |
| Sep 2019 | - | $1.50 M(+142.0%) |
| Jun 2019 | $621.00 K(+5.3%) | $621.00 K(+1.3%) |
| Mar 2019 | - | $613.00 K(+1.2%) |
| Dec 2018 | - | $606.00 K(+1.3%) |
| Sep 2018 | - | $598.00 K(+1.4%) |
| Jun 2018 | $590.00 K(+5.2%) | $590.00 K(+1.2%) |
| Mar 2018 | - | $583.00 K(+1.2%) |
| Dec 2017 | - | $576.00 K(+1.4%) |
| Sep 2017 | - | $568.00 K(+1.2%) |
| Jun 2017 | $561.00 K(-7.6%) | $561.00 K(+1.3%) |
| Mar 2017 | - | $554.00 K(+1.3%) |
| Dec 2016 | - | $547.00 K(-7.0%) |
| Sep 2016 | - | $588.00 K(-3.1%) |
| Jun 2016 | $607.00 K(-46.2%) | $607.00 K(-42.7%) |
| Mar 2016 | - | $1.06 M(-5.0%) |
| Dec 2015 | - | $1.11 M(-1.8%) |
| Sep 2015 | - | $1.14 M(+0.6%) |
| Jun 2015 | $1.13 M(-21.6%) | $1.13 M(+2.0%) |
| Mar 2015 | - | $1.11 M(-0.8%) |
| Dec 2014 | - | $1.12 M(-1.8%) |
| Sep 2014 | - | $1.14 M(-21.1%) |
| Jun 2014 | $1.44 M(+60.6%) | $1.44 M(-5.6%) |
| Mar 2014 | - | $1.53 M(+79.1%) |
| Dec 2013 | - | $851.60 K(-10.4%) |
| Sep 2013 | - | $950.20 K(+6.0%) |
| Jun 2013 | $896.20 K(-13.7%) | $896.20 K(-1.0%) |
| Mar 2013 | - | $905.70 K(-9.2%) |
| Dec 2012 | - | $997.50 K(+7.8%) |
| Sep 2012 | - | $925.70 K(-10.8%) |
| Jun 2012 | $1.04 M | $1.04 M(+27.7%) |
| Mar 2012 | - | $813.10 K(-19.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $1.01 M(+49.2%) |
| Sep 2011 | - | $677.20 K(+2.3%) |
| Jun 2011 | $662.20 K(-10.0%) | $662.20 K(-31.3%) |
| Mar 2011 | - | $964.50 K(-52.7%) |
| Dec 2010 | - | $2.04 M(+176.8%) |
| Sep 2010 | - | $736.60 K(+0.1%) |
| Jun 2010 | $735.90 K(+0.9%) | $735.90 K(+0.1%) |
| Mar 2010 | - | $735.30 K(+0.1%) |
| Dec 2009 | - | $734.70 K(+0.6%) |
| Sep 2009 | - | $730.40 K(+0.1%) |
| Jun 2009 | $729.50 K(-14.3%) | $729.50 K(-0.5%) |
| Mar 2009 | - | $732.80 K(+0.1%) |
| Dec 2008 | - | $732.30 K(-13.4%) |
| Sep 2008 | - | $845.90 K(-0.6%) |
| Jun 2008 | $850.90 K(+53.6%) | $850.90 K(-5.7%) |
| Mar 2008 | - | $902.20 K(-9.5%) |
| Dec 2007 | - | $997.00 K(-0.9%) |
| Sep 2007 | - | $1.01 M(+81.6%) |
| Jun 2007 | $553.80 K(-36.3%) | $553.80 K(-18.5%) |
| Mar 2007 | - | $679.70 K(-8.2%) |
| Dec 2006 | - | $740.70 K(-7.6%) |
| Sep 2006 | - | $801.20 K(-7.8%) |
| Jun 2006 | $869.40 K(>+9900.0%) | $869.40 K(-10.4%) |
| Mar 2006 | - | $970.60 K(-28.5%) |
| Dec 2005 | - | $1.36 M(-71.1%) |
| Sep 2005 | - | $4.70 M(>+9900.0%) |
| Mar 2005 | - | $500.00(>+9900.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) |
| Sep 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | - | $0.00(0.0%) |
| Sep 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | - | $93.10 K(>+9900.0%) |
| Sep 2000 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) |
| Dec 1999 | - | $0.00(0.0%) |
| Sep 1999 | $0.00(0.0%) | $0.00 |
| Sep 1998 | $0.00(-100.0%) | - |
| Sep 1997 | $161.50 K(-57.1%) | - |
| Sep 1996 | $376.40 K(-33.0%) | - |
| Sep 1995 | $562.20 K(-22.2%) | - |
| Sep 1994 | $722.90 K | - |
FAQ
- What is Perspective Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Perspective Therapeutics?
- What is Perspective Therapeutics annual total long term liabilities year-on-year change?
- What is Perspective Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly long term liabilities year-on-year change?
What is Perspective Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CATX is $7.05 M
What is the all time high annual total long term liabilities for Perspective Therapeutics?
Perspective Therapeutics all-time high annual total long term liabilities is $7.05 M
What is Perspective Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CATX annual total long term liabilities has changed by +$6.28 M (+811.77%)
What is Perspective Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CATX is $34.54 M
What is the all time high quarterly long term liabilities for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly total long term liabilities is $34.54 M
What is Perspective Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CATX quarterly total long term liabilities has changed by +$30.91 M (+850.70%)